ReEmerge is a private MedTech company developing Cognitive Network Restoration Therapy (CNRT), an investigational neuromodulation approach that targets neural networks in the central thalamus disrupted by brain injury and drives underactive but viable circuits, aiming to reverse chronic cognitive deficits rather than compensate for them. The technology builds on central thalamic deep brain stimulation research by Nicholas Schiff and colleagues at Weill Cornell Medicine and is advanced under an exclusive licensing agreement with Cornell University. Its first clinical indication is chronic moderate-to-severe traumatic brain injury, where a prospective multicenter clinical study is being prepared.
1
Round
1
Industry
4
Tags
Sep 15, 2026
Latest raise
Funding activity · 1 round
Sep 15, 2026
$37M
Series A
Led by U.S. Venture Partners (USVP)
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
